We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NeuroCDRD: Development Platform for Neurological Disease Therapies

News   Mar 31, 2017 | Original Story from the Centre for Drug Research and Development, Canada.

 
NeuroCDRD: Development Platform for Neurological Disease Therapies
 
 
 

RELATED ARTICLES

670,000 Person Study Suggests Sex Differences and Autistic Traits Have Impacts on Cognitive Empathy

News

Scientists have completed the world’s largest ever study of typical sex differences and autistic traits, involving well over half a million people. They tested and confirmed two long-standing psychological theories: the Empathising-Systemising theory of sex differences and the Extreme Male Brain theory of autism.

READ MORE

Personalized Implants Designed to Improve Organ Transplant Success

News

Host-derived scaffolding material may reduce the chance of organ transplant rejection.

READ MORE

The Role of Oligodendrocytes in MS

News

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE